C21H20Cl2N2O5S
Neat
483.37
-20°C
Room Temperature
134071-44-6; Ketoconazole impurity E [EP]; 1, 3-Dioxolane-4-methanol, 2-(2, 4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-, 4-(4-methylbenzenesulfonate), (2R, 4R)-rel-; 2-(2, 4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1, 3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate; 644X337Z6T; EC 603-791-6; DTXSID701105119; 1, 3-Dioxolane-4-methanol, 2-(2, 4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-, 4-methylbenzenesulfonate (ester), (2R, 4R)-rel-; 1, 3-Dioxolane-4-methanol, 2-(2, 4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-, 4-methylbenzenesulfonate (ester), cis-; KETOCONAZOLE IMPURITY E [EP IMPURITY]; KETOCONAZOLE IMPURITY E (EP IMPURITY); Ketoconazole Impurity E; RefChem:451945; DTXCID801536795; 603-791-6; (cis-2-((1H-Imidazol-1-yl)methyl)-2-(2, 4-dichlorophenyl)-1, 3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate; Ketoconazole EP Impurity E; ((2R, 4R)-rel-2-((1H-Imidazol-1-yl)methyl)-2-(2, 4-dichlorophenyl)-1, 3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate; MFCD23843811; (+/-)-2-(2, 4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1 and 3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate
[(2R, 4R)-2-(2, 4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1 and 3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate
InChI=1S/C21H20Cl2N2O5S/c1-15-2-5-18(6-3-15)31(26,27)29-12-17-11-28-21(30-17,13-25-9-8-24-14-25)19-7-4-16(22)10-20(19)23/h2-10,14,17H,11-13H2,1H3/t17-,21+/m1/s1